423 related articles for article (PubMed ID: 21797846)
1. Inhibitory kappa B Kinases as targets for pharmacological regulation.
Gamble C; McIntosh K; Scott R; Ho KH; Plevin R; Paul A
Br J Pharmacol; 2012 Feb; 165(4):802-19. PubMed ID: 21797846
[TBL] [Abstract][Full Text] [Related]
2. The small-molecule inhibitor selectivity between IKKα and IKKβ kinases in NF-κB signaling pathway.
Tian F; Zhou P; Kang W; Luo L; Fan X; Yan J; Liang H
J Recept Signal Transduct Res; 2015; 35(4):307-18. PubMed ID: 25386663
[TBL] [Abstract][Full Text] [Related]
3. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
4. Targeting IκappaB kinases for cancer therapy.
Awasthee N; Rai V; Chava S; Nallasamy P; Kunnumakkara AB; Bishayee A; Chauhan SC; Challagundla KB; Gupta SC
Semin Cancer Biol; 2019 Jun; 56():12-24. PubMed ID: 29486318
[TBL] [Abstract][Full Text] [Related]
5. Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer.
Nottingham LK; Yan CH; Yang X; Si H; Coupar J; Bian Y; Cheng TF; Allen C; Arun P; Gius D; Dang L; Van Waes C; Chen Z
Oncogene; 2014 Feb; 33(9):1135-47. PubMed ID: 23455325
[TBL] [Abstract][Full Text] [Related]
6. IKKα plays a major role in canonical NF-κB signalling in colorectal cells.
Prescott JA; Balmanno K; Mitchell JP; Okkenhaug H; Cook SJ
Biochem J; 2022 Feb; 479(3):305-325. PubMed ID: 35029639
[TBL] [Abstract][Full Text] [Related]
7. Protein Kinase-Mediated Decision Between the Life and Death.
Engin A
Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
[TBL] [Abstract][Full Text] [Related]
8. The IkappaB kinase complex: master regulator of NF-kappaB signaling.
Solt LA; May MJ
Immunol Res; 2008; 42(1-3):3-18. PubMed ID: 18626576
[TBL] [Abstract][Full Text] [Related]
9. NEMO-binding domains of both IKKalpha and IKKbeta regulate IkappaB kinase complex assembly and classical NF-kappaB activation.
Solt LA; Madge LA; May MJ
J Biol Chem; 2009 Oct; 284(40):27596-608. PubMed ID: 19666475
[TBL] [Abstract][Full Text] [Related]
10. Targeting IKKβ for the treatment of rheumatoid arthritis.
Bamborough P; Morse MA; Ray KP
Drug News Perspect; 2010 Oct; 23(8):483-90. PubMed ID: 21031164
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1-induced NF-kappaB activation is NEMO-dependent but does not require IKKbeta.
Solt LA; Madge LA; Orange JS; May MJ
J Biol Chem; 2007 Mar; 282(12):8724-33. PubMed ID: 17244613
[TBL] [Abstract][Full Text] [Related]
13. Prognostic values of inhibitory κB kinases mRNA expression in human gastric cancer.
Gayed DT; Wodeyar J; Wang ZX; Wei X; Yao YY; Chen XX; Du Z; Chen JC
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30487159
[No Abstract] [Full Text] [Related]
14. CaMKIIδ interacts directly with IKKβ and modulates NF-κB signalling in adult cardiac fibroblasts.
Martin TP; McCluskey C; Cunningham MR; Beattie J; Paul A; Currie S
Cell Signal; 2018 Nov; 51():166-175. PubMed ID: 30059730
[TBL] [Abstract][Full Text] [Related]
15. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
[TBL] [Abstract][Full Text] [Related]
16. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
17. Small molecule binding to inhibitor of nuclear factor kappa-B kinase subunit beta in an ATP non-competitive manner.
Napoleon JV; Singh S; Rana S; Bendjennat M; Kumar V; Kizhake S; Palermo NY; Ouellette MM; Huxford T; Natarajan A
Chem Commun (Camb); 2021 May; 57(38):4678-4681. PubMed ID: 33977973
[TBL] [Abstract][Full Text] [Related]
18. Novel tight-binding inhibitory factor-kappaB kinase (IKK-2) inhibitors demonstrate target-specific anti-inflammatory activities in cellular assays and following oral and local delivery in an in vivo model of airway inflammation.
Sommers CD; Thompson JM; Guzova JA; Bonar SL; Rader RK; Mathialagan S; Venkatraman N; Holway VW; Kahn LE; Hu G; Garner DS; Huang HC; Chiang PC; Schindler JF; Hu Y; Meyer DM; Kishore NN
J Pharmacol Exp Ther; 2009 Aug; 330(2):377-88. PubMed ID: 19478133
[TBL] [Abstract][Full Text] [Related]
19. Novel cross-talk within the IKK family controls innate immunity.
Clark K; Peggie M; Plater L; Sorcek RJ; Young ER; Madwed JB; Hough J; McIver EG; Cohen P
Biochem J; 2011 Feb; 434(1):93-104. PubMed ID: 21138416
[TBL] [Abstract][Full Text] [Related]
20. A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts.
Kishore N; Sommers C; Mathialagan S; Guzova J; Yao M; Hauser S; Huynh K; Bonar S; Mielke C; Albee L; Weier R; Graneto M; Hanau C; Perry T; Tripp CS
J Biol Chem; 2003 Aug; 278(35):32861-71. PubMed ID: 12813046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
